|
1
|
<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
|
|
2
|
<ns2:medicines xmlns:ns2="http://www.msh.org/quantb/model/medicine">
|
|
3
|
<medicines>
|
|
4
|
<name>Amikacin</name>
|
|
5
|
<abbrevName>Am(500)</abbrevName>
|
|
6
|
<strength>500mg</strength>
|
|
7
|
<form>POWDER_FOR_INJECTION</form>
|
|
8
|
<dosage></dosage>
|
|
9
|
<type>Second_Line_Parenteral_Agent</type>
|
|
10
|
</medicines>
|
|
11
|
<medicines>
|
|
12
|
<name>Amikacin</name>
|
|
13
|
<abbrevName>Am(500/2)</abbrevName>
|
|
14
|
<strength>500mg/2ml</strength>
|
|
15
|
<form>SOLUTION_FOR_INJECTION</form>
|
|
16
|
<dosage></dosage>
|
|
17
|
<type>Second_Line_Parenteral_Agent</type>
|
|
18
|
</medicines>
|
|
19
|
<medicines>
|
|
20
|
<name>Capreomycin</name>
|
|
21
|
<abbrevName>Cm(1000)</abbrevName>
|
|
22
|
<strength>1000mg</strength>
|
|
23
|
<form>POWDER_FOR_INJECTION</form>
|
|
24
|
<dosage></dosage>
|
|
25
|
<type>Second_Line_Parenteral_Agent</type>
|
|
26
|
</medicines>
|
|
27
|
<medicines>
|
|
28
|
<name>Imipenem + Cilastatin</name>
|
|
29
|
<abbrevName>Imi/Cls(500/500)</abbrevName>
|
|
30
|
<strength>500mg+500mg</strength>
|
|
31
|
<form>POWDER_FOR_INJECTION</form>
|
|
32
|
<dosage></dosage>
|
|
33
|
<type>Group_5</type>
|
|
34
|
</medicines>
|
|
35
|
<medicines>
|
|
36
|
<name>Kanamycin</name>
|
|
37
|
<abbrevName>Km(1000)</abbrevName>
|
|
38
|
<strength>1000mg</strength>
|
|
39
|
<form>POWDER_FOR_INJECTION</form>
|
|
40
|
<dosage></dosage>
|
|
41
|
<type>Second_Line_Parenteral_Agent</type>
|
|
42
|
</medicines>
|
|
43
|
<medicines>
|
|
44
|
<name>Kanamycin</name>
|
|
45
|
<abbrevName>Km(1000/4)</abbrevName>
|
|
46
|
<strength>1000mg/4ml</strength>
|
|
47
|
<form>SOLUTION_FOR_INJECTION</form>
|
|
48
|
<dosage></dosage>
|
|
49
|
<type>Second_Line_Parenteral_Agent</type>
|
|
50
|
</medicines>
|
|
51
|
<medicines>
|
|
52
|
<name>Streptomycin</name>
|
|
53
|
<abbrevName>S(1000)</abbrevName>
|
|
54
|
<strength>1000mg</strength>
|
|
55
|
<form>POWDER_FOR_INJECTION</form>
|
|
56
|
<dosage></dosage>
|
|
57
|
<type>First_Line</type>
|
|
58
|
</medicines>
|
|
59
|
<medicines>
|
|
60
|
<name>Amoxicillin + Clavulanic acid</name>
|
|
61
|
<abbrevName>Amx/Clv(250/125)</abbrevName>
|
|
62
|
<strength>250mg+125mg</strength>
|
|
63
|
<form>FILM_COATED_TABLET</form>
|
|
64
|
<dosage></dosage>
|
|
65
|
<type>Group_5</type>
|
|
66
|
</medicines>
|
|
67
|
<medicines>
|
|
68
|
<name>Amoxicillin + Clavulanic acid</name>
|
|
69
|
<abbrevName>Amx/Clv(500/125)</abbrevName>
|
|
70
|
<strength>500mg+125mg</strength>
|
|
71
|
<form>FILM_COATED_TABLET</form>
|
|
72
|
<dosage></dosage>
|
|
73
|
<type>Group_5</type>
|
|
74
|
</medicines>
|
|
75
|
<medicines>
|
|
76
|
<name>Amoxicillin + Potassium clavulanate</name>
|
|
77
|
<abbrevName>Amx/Clv(875/125)</abbrevName>
|
|
78
|
<strength>875mg+125mg</strength>
|
|
79
|
<form>FILM_COATED_TABLET</form>
|
|
80
|
<dosage></dosage>
|
|
81
|
<type>Group_5</type>
|
|
82
|
</medicines>
|
|
83
|
<medicines>
|
|
84
|
<name>Clofazimine</name>
|
|
85
|
<abbrevName>Cfz(100)</abbrevName>
|
|
86
|
<strength>100mg</strength>
|
|
87
|
<form>CAPSULE</form>
|
|
88
|
<dosage></dosage>
|
|
89
|
<type>Group_5</type>
|
|
90
|
</medicines>
|
|
91
|
<medicines>
|
|
92
|
<name>Clarithromycin</name>
|
|
93
|
<abbrevName>Clr(250)</abbrevName>
|
|
94
|
<strength>250mg</strength>
|
|
95
|
<form>FILM_COATED_TABLET</form>
|
|
96
|
<dosage></dosage>
|
|
97
|
<type>Group_5</type>
|
|
98
|
</medicines>
|
|
99
|
<medicines>
|
|
100
|
<name>Clarithromycin</name>
|
|
101
|
<abbrevName>Clr(500)</abbrevName>
|
|
102
|
<strength>500mg</strength>
|
|
103
|
<form>FILM_COATED_TABLET</form>
|
|
104
|
<dosage></dosage>
|
|
105
|
<type>Group_5</type>
|
|
106
|
</medicines>
|
|
107
|
<medicines>
|
|
108
|
<name>Cycloserine</name>
|
|
109
|
<abbrevName>Cs(250)</abbrevName>
|
|
110
|
<strength>250mg</strength>
|
|
111
|
<form>CAPSULE</form>
|
|
112
|
<dosage></dosage>
|
|
113
|
<type>Second_Line_Oral_Bacteriostatic </type>
|
|
114
|
</medicines>
|
|
115
|
<medicines>
|
|
116
|
<name>Ethambutol</name>
|
|
117
|
<abbrevName>E(100)</abbrevName>
|
|
118
|
<strength>100mg</strength>
|
|
119
|
<form>FILM_COATED_TABLET</form>
|
|
120
|
<dosage></dosage>
|
|
121
|
<type>Pediatric</type>
|
|
122
|
</medicines>
|
|
123
|
<medicines>
|
|
124
|
<name>Ethambutol</name>
|
|
125
|
<abbrevName>E(400)</abbrevName>
|
|
126
|
<strength>400mg</strength>
|
|
127
|
<form>FILM_COATED_TABLET</form>
|
|
128
|
<dosage></dosage>
|
|
129
|
<type>First_Line</type>
|
|
130
|
</medicines>
|
|
131
|
<medicines>
|
|
132
|
<name>Ethambutol</name>
|
|
133
|
<abbrevName>E(800)</abbrevName>
|
|
134
|
<strength>800mg</strength>
|
|
135
|
<form>FILM_COATED_TABLET</form>
|
|
136
|
<dosage></dosage>
|
|
137
|
<type>First_Line</type>
|
|
138
|
</medicines>
|
|
139
|
<medicines>
|
|
140
|
<name>2-FDC EH (400/150)</name>
|
|
141
|
<abbrevName>EH(400/150)</abbrevName>
|
|
142
|
<strength>400mg+150mg</strength>
|
|
143
|
<form>FILM_COATED_TABLET</form>
|
|
144
|
<dosage></dosage>
|
|
145
|
<type>First_Line</type>
|
|
146
|
</medicines>
|
|
147
|
<medicines>
|
|
148
|
<name>Ethionamide</name>
|
|
149
|
<abbrevName>Eto(125)</abbrevName>
|
|
150
|
<strength>125mg</strength>
|
|
151
|
<form>FILM_COATED_TABLET</form>
|
|
152
|
<dosage></dosage>
|
|
153
|
<type>Second_Line_Oral_Bacteriostatic </type>
|
|
154
|
</medicines>
|
|
155
|
<medicines>
|
|
156
|
<name>Ethionamide</name>
|
|
157
|
<abbrevName>Eto(250)</abbrevName>
|
|
158
|
<strength>250mg</strength>
|
|
159
|
<form>FILM_COATED_TABLET</form>
|
|
160
|
<dosage></dosage>
|
|
161
|
<type>Second_Line_Oral_Bacteriostatic </type>
|
|
162
|
</medicines>
|
|
163
|
<medicines>
|
|
164
|
<name>Isoniazid</name>
|
|
165
|
<abbrevName>H(100)</abbrevName>
|
|
166
|
<strength>100mg</strength>
|
|
167
|
<form>DISPERSIBLE_TABLET</form>
|
|
168
|
<dosage></dosage>
|
|
169
|
<type>Pediatric</type>
|
|
170
|
</medicines>
|
|
171
|
<medicines>
|
|
172
|
<name>Isoniazid</name>
|
|
173
|
<abbrevName>H(300)</abbrevName>
|
|
174
|
<strength>300mg</strength>
|
|
175
|
<form>FILM_UNCOATED_TABLET</form>
|
|
176
|
<dosage></dosage>
|
|
177
|
<type>First_Line</type>
|
|
178
|
</medicines>
|
|
179
|
<medicines>
|
|
180
|
<name>Levofloxacin</name>
|
|
181
|
<abbrevName>Lfx(250)</abbrevName>
|
|
182
|
<strength>250mg</strength>
|
|
183
|
<form>FILM_COATED_TABLET</form>
|
|
184
|
<dosage></dosage>
|
|
185
|
<type>Fluoroquinolones</type>
|
|
186
|
</medicines>
|
|
187
|
<medicines>
|
|
188
|
<name>Levofloxacin</name>
|
|
189
|
<abbrevName>Lfx(500)</abbrevName>
|
|
190
|
<strength>500mg</strength>
|
|
191
|
<form>FILM_COATED_TABLET</form>
|
|
192
|
<dosage></dosage>
|
|
193
|
<type>Fluoroquinolones</type>
|
|
194
|
</medicines>
|
|
195
|
<medicines>
|
|
196
|
<name>Linezolid</name>
|
|
197
|
<abbrevName>Lnz(600)</abbrevName>
|
|
198
|
<strength>600mg</strength>
|
|
199
|
<form>FILM_COATED_TABLET</form>
|
|
200
|
<dosage></dosage>
|
|
201
|
<type>Group_5</type>
|
|
202
|
</medicines>
|
|
203
|
<medicines>
|
|
204
|
<name>Moxifloxacin</name>
|
|
205
|
<abbrevName>Mfx(400)</abbrevName>
|
|
206
|
<strength>400mg</strength>
|
|
207
|
<form>FILM_COATED_TABLET</form>
|
|
208
|
<dosage></dosage>
|
|
209
|
<type>Fluoroquinolones</type>
|
|
210
|
</medicines>
|
|
211
|
<medicines>
|
|
212
|
<name>Ofloxacin</name>
|
|
213
|
<abbrevName>Ofx(200)</abbrevName>
|
|
214
|
<strength>200mg</strength>
|
|
215
|
<form>FILM_COATED_TABLET</form>
|
|
216
|
<dosage></dosage>
|
|
217
|
<type>Fluoroquinolones</type>
|
|
218
|
</medicines>
|
|
219
|
<medicines>
|
|
220
|
<name>Ofloxacin</name>
|
|
221
|
<abbrevName>Ofx(400)</abbrevName>
|
|
222
|
<strength>400mg</strength>
|
|
223
|
<form>FILM_COATED_TABLET</form>
|
|
224
|
<dosage></dosage>
|
|
225
|
<type>Fluoroquinolones</type>
|
|
226
|
</medicines>
|
|
227
|
<medicines>
|
|
228
|
<name>P-aminosalicylic acid</name>
|
|
229
|
<abbrevName>PAS</abbrevName>
|
|
230
|
<strength>4000mg</strength>
|
|
231
|
<form>OTHER</form>
|
|
232
|
<dosage>Granules/Sachet</dosage>
|
|
233
|
<type>Second_Line_Oral_Bacteriostatic </type>
|
|
234
|
</medicines>
|
|
235
|
<medicines>
|
|
236
|
<name>p-Aminosalicylate sodium 5.52 g </name>
|
|
237
|
<abbrevName>PAS ( Na) salt 5.52g </abbrevName>
|
|
238
|
<strength>4 G PAS acid / 5.52 g sachet</strength>
|
|
239
|
<form>OTHER</form>
|
|
240
|
<dosage>Sachet </dosage>
|
|
241
|
<type>Second_Line_Oral_Bacteriostatic </type>
|
|
242
|
</medicines>
|
|
243
|
<medicines>
|
|
244
|
<name>P-aminosalicylate sodium delayed-release granulses ( 60% )</name>
|
|
245
|
<abbrevName>PAS sodium 60% granules</abbrevName>
|
|
246
|
<strength>100G</strength>
|
|
247
|
<form>GRANULE</form>
|
|
248
|
<dosage></dosage>
|
|
249
|
<type>Second_Line_Oral_Bacteriostatic </type>
|
|
250
|
</medicines>
|
|
251
|
<medicines>
|
|
252
|
<name>P-aminosalicylate sodium delayed-release granules (60% w/w)</name>
|
|
253
|
<abbrevName>PAS(Na 60% w/w)</abbrevName>
|
|
254
|
<strength>4000mg</strength>
|
|
255
|
<form>OTHER</form>
|
|
256
|
<dosage>Granules/Sachet</dosage>
|
|
257
|
<type>Second_Line_Oral_Bacteriostatic </type>
|
|
258
|
</medicines>
|
|
259
|
<medicines>
|
|
260
|
<name>P-aminosalicylate sodium salt</name>
|
|
261
|
<abbrevName>PAS(Na)</abbrevName>
|
|
262
|
<strength>4000mg</strength>
|
|
263
|
<form>OTHER</form>
|
|
264
|
<dosage>Powder/Sachet</dosage>
|
|
265
|
<type>Second_Line_Oral_Bacteriostatic </type>
|
|
266
|
</medicines>
|
|
267
|
<medicines>
|
|
268
|
<name>Initial Regime- Patient Kit</name>
|
|
269
|
<abbrevName>PK</abbrevName>
|
|
270
|
<strength>2 kit RHZE/4 kit RH</strength>
|
|
271
|
<form>FILM_COATED_TABLET</form>
|
|
272
|
<dosage></dosage>
|
|
273
|
<type>First_Line</type>
|
|
274
|
</medicines>
|
|
275
|
<medicines>
|
|
276
|
<name>Protionamide </name>
|
|
277
|
<abbrevName>Pto(250)</abbrevName>
|
|
278
|
<strength>250mg</strength>
|
|
279
|
<form>FILM_COATED_TABLET</form>
|
|
280
|
<dosage></dosage>
|
|
281
|
<type>Second_Line_Oral_Bacteriostatic </type>
|
|
282
|
</medicines>
|
|
283
|
<medicines>
|
|
284
|
<name>Rifampicin</name>
|
|
285
|
<abbrevName>R(150)</abbrevName>
|
|
286
|
<strength>150mg</strength>
|
|
287
|
<form>FILM_COATED_TABLET</form>
|
|
288
|
<dosage></dosage>
|
|
289
|
<type>First_Line</type>
|
|
290
|
</medicines>
|
|
291
|
<medicines>
|
|
292
|
<name>Rifampicin</name>
|
|
293
|
<abbrevName>R(300)</abbrevName>
|
|
294
|
<strength>300mg</strength>
|
|
295
|
<form>FILM_COATED_TABLET</form>
|
|
296
|
<dosage></dosage>
|
|
297
|
<type>First_Line</type>
|
|
298
|
</medicines>
|
|
299
|
<medicines>
|
|
300
|
<name>2-FDC RH (150/150)</name>
|
|
301
|
<abbrevName>RH(150/150)</abbrevName>
|
|
302
|
<strength>150mg+150mg</strength>
|
|
303
|
<form>FILM_COATED_TABLET</form>
|
|
304
|
<dosage></dosage>
|
|
305
|
<type>First_Line</type>
|
|
306
|
</medicines>
|
|
307
|
<medicines>
|
|
308
|
<name>2-FDC RH (150/75)</name>
|
|
309
|
<abbrevName>RH(150/75)</abbrevName>
|
|
310
|
<strength>150mg+75mg</strength>
|
|
311
|
<form>FILM_COATED_TABLET</form>
|
|
312
|
<dosage></dosage>
|
|
313
|
<type>First_Line</type>
|
|
314
|
</medicines>
|
|
315
|
<medicines>
|
|
316
|
<name>2-FDC RH (60/30)</name>
|
|
317
|
<abbrevName>RH(60/30)</abbrevName>
|
|
318
|
<strength>60mg+30mg</strength>
|
|
319
|
<form>DISPERSIBLE_TABLET</form>
|
|
320
|
<dosage></dosage>
|
|
321
|
<type>Pediatric</type>
|
|
322
|
</medicines>
|
|
323
|
<medicines>
|
|
324
|
<name>2-FDC RH (60/60)</name>
|
|
325
|
<abbrevName>RH(60/60)</abbrevName>
|
|
326
|
<strength>60mg+60mg</strength>
|
|
327
|
<form>DISPERSIBLE_TABLET</form>
|
|
328
|
<dosage></dosage>
|
|
329
|
<type>Pediatric</type>
|
|
330
|
</medicines>
|
|
331
|
<medicines>
|
|
332
|
<name>3-FDC RHE (150/75/275)</name>
|
|
333
|
<abbrevName>RHE(150/75/275)</abbrevName>
|
|
334
|
<strength>150mg+75mg+275mg</strength>
|
|
335
|
<form>FILM_COATED_TABLET</form>
|
|
336
|
<dosage></dosage>
|
|
337
|
<type>First_Line</type>
|
|
338
|
</medicines>
|
|
339
|
<medicines>
|
|
340
|
<name>3-FDC RHZ (60/30/150)</name>
|
|
341
|
<abbrevName>RHZ(60/30/150)</abbrevName>
|
|
342
|
<strength>60mg+30mg+150mg</strength>
|
|
343
|
<form>DISPERSIBLE_TABLET</form>
|
|
344
|
<dosage></dosage>
|
|
345
|
<type>Pediatric</type>
|
|
346
|
</medicines>
|
|
347
|
<medicines>
|
|
348
|
<name>4-FDC RHZE (150/75/400/275)</name>
|
|
349
|
<abbrevName>RHZE(150/75/400/275)</abbrevName>
|
|
350
|
<strength>150mg+75mg+400mg+275mg</strength>
|
|
351
|
<form>FILM_COATED_TABLET</form>
|
|
352
|
<dosage></dosage>
|
|
353
|
<type>First_Line</type>
|
|
354
|
</medicines>
|
|
355
|
<medicines>
|
|
356
|
<name>Rifabutin</name>
|
|
357
|
<abbrevName>Rbt(150)</abbrevName>
|
|
358
|
<strength>150mg</strength>
|
|
359
|
<form>CAPSULE</form>
|
|
360
|
<dosage></dosage>
|
|
361
|
<type>Group_5</type>
|
|
362
|
</medicines>
|
|
363
|
<medicines>
|
|
364
|
<name>Syringe & needle (auto-disabling)</name>
|
|
365
|
<abbrevName>S&N-5/21Gx1.5 and Safety Box </abbrevName>
|
|
366
|
<strength>21G</strength>
|
|
367
|
<form>NA</form>
|
|
368
|
<dosage>Syringe & needle </dosage>
|
|
369
|
<type>Other</type>
|
|
370
|
</medicines>
|
|
371
|
<medicines>
|
|
372
|
<name>Syringe & needle (auto-disabling)</name>
|
|
373
|
<abbrevName>S&N-5/22Gx1.5 and Safety Box </abbrevName>
|
|
374
|
<strength>22G</strength>
|
|
375
|
<form>NA</form>
|
|
376
|
<dosage>Syringe & needle </dosage>
|
|
377
|
<type>Other</type>
|
|
378
|
</medicines>
|
|
379
|
<medicines>
|
|
380
|
<name>Syringe & needle (auto-disabling)</name>
|
|
381
|
<abbrevName>S&N-5/23Gx1 and Safety Box </abbrevName>
|
|
382
|
<strength>23G</strength>
|
|
383
|
<dosage>Syringe & needle </dosage>
|
|
384
|
<type>Other</type>
|
|
385
|
</medicines>
|
|
386
|
<medicines>
|
|
387
|
<name>Terizidone</name>
|
|
388
|
<abbrevName>Trd(250)</abbrevName>
|
|
389
|
<strength>250mg</strength>
|
|
390
|
<form>CAPSULE</form>
|
|
391
|
<dosage></dosage>
|
|
392
|
<type>Second_Line_Oral_Bacteriostatic </type>
|
|
393
|
</medicines>
|
|
394
|
<medicines>
|
|
395
|
<name>Pyridoxine</name>
|
|
396
|
<abbrevName>Vit-B6(100)</abbrevName>
|
|
397
|
<strength>100mg</strength>
|
|
398
|
<form>FILM_UNCOATED_TABLET</form>
|
|
399
|
<dosage></dosage>
|
|
400
|
<type>Other</type>
|
|
401
|
</medicines>
|
|
402
|
<medicines>
|
|
403
|
<name>Pyridoxine</name>
|
|
404
|
<abbrevName>Vit-B6(50)</abbrevName>
|
|
405
|
<strength>50mg</strength>
|
|
406
|
<form>FILM_UNCOATED_TABLET</form>
|
|
407
|
<dosage></dosage>
|
|
408
|
<type>Other</type>
|
|
409
|
</medicines>
|
|
410
|
<medicines>
|
|
411
|
<name>Water for injection</name>
|
|
412
|
<abbrevName>WFI(5)</abbrevName>
|
|
413
|
<strength>5ml</strength>
|
|
414
|
<form>NA</form>
|
|
415
|
<dosage>Water</dosage>
|
|
416
|
<type>Other</type>
|
|
417
|
</medicines>
|
|
418
|
<medicines>
|
|
419
|
<name>Pyrazinamide</name>
|
|
420
|
<abbrevName>Z(400)</abbrevName>
|
|
421
|
<strength>400mg</strength>
|
|
422
|
<form>FILM_UNCOATED_TABLET</form>
|
|
423
|
<dosage></dosage>
|
|
424
|
<type>First_Line</type>
|
|
425
|
</medicines>
|
|
426
|
<medicines>
|
|
427
|
<name>Pyrazinamide</name>
|
|
428
|
<abbrevName>Z(500)</abbrevName>
|
|
429
|
<strength>500mg</strength>
|
|
430
|
<form>FILM_UNCOATED_TABLET</form>
|
|
431
|
<dosage></dosage>
|
|
432
|
<type>First_Line</type>
|
|
433
|
</medicines>
|
|
434
|
<medicines>
|
|
435
|
<name>Pyrazinamide</name>
|
|
436
|
<abbrevName>Z(750)</abbrevName>
|
|
437
|
<strength>750mg</strength>
|
|
438
|
<form>FILM_UNCOATED_TABLET</form>
|
|
439
|
<dosage></dosage>
|
|
440
|
<type>First_Line</type>
|
|
441
|
</medicines>
|
|
442
|
<medicines>
|
|
443
|
<name>Bedaquline</name>
|
|
444
|
<abbrevName>Bdq</abbrevName>
|
|
445
|
<strength>100mg</strength>
|
|
446
|
<form>FILM_COATED_TABLET</form>
|
|
447
|
<dosage></dosage>
|
|
448
|
<type>Group_5</type>
|
|
449
|
</medicines>
|
|
450
|
<stamp name="USER">
|
|
451
|
<lastUpdated>2015-11-03T14:22:55.814+06:30</lastUpdated>
|
|
452
|
</stamp>
|
|
453
|
</ns2:medicines>
|